PRIMARY STUDY
Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy
Key Findings: Compared to health controls, normotensive patients with immunoglobin A nephropathy had higher levels of liver-type fatty acid-binding protein (L-FABP) and 8-hydroxydeoxyguanosine (8-OHdG) and a combination therapy of an angiotensin receptor blocker (ARB) plus an angiotensin-converting enzyme inhibitor (ACEI) had a greater benefit on renal function.
Type of Study: Clinical Trial
Study Sample Size: 24
Study Result: Positive
Research Location(s): Japan
Year of Pub: 2024
Cannabinoids Studied: Fatty Acid Amide Hydrolase (FAAH)
Phytocannabinoid Source: Not Applicable
Citation: Nakamura T, et al. Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy. Am J Hypertens. 2007; 20:1195-201. doi: 10.1016/j.amjhyper.2007.06.003
Authors: Nakamura T, Inoue T, Sugaya T, Kawagoe Y, Suzuki T, Ueda Y, Koide H, Node K
